Insmed Inc. Stock
Price
Target price
€20.20
€20.20
-4.720%
-1.0
-4.720%
€44.16
27.05.24 / Stuttgart Stock Exchange
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insmed Inc. Stock
Heavy losses for Insmed Inc. today as the stock fell by -€1.000 (-4.720%).
With 19 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 20.2 € the target price of 44 € shows a potential of 117.82% for Insmed Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insmed Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insmed Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | -4.720% | -11.404% | -12.174% | 17.442% | -29.371% | 3.061% | -13.081% |
| Evolus Inc | -3.480% | -8.264% | 5.714% | 36.196% | 22.652% | 27.586% | - |
| Ardelyx Inc. | 0.810% | -11.062% | 7.005% | 109.673% | 11.003% | 7.832% | - |
| Salarius Pharmaceuticals Inc. | 2.010% | -2.404% | -4.695% | -66.721% | -26.847% | -98.343% | -99.993% |
Comments
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $48.00 price target on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $40.00 to $49.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $52.00 price target on the stock.
Show more
Ratings data for INSM provided by MarketBeat